Evaluation of three-dimensional right ventricular function and reverse remodelling in patients undergoing percutaneous mitral valve repair for functional mitral regurgitation: insights from a multicentre Italian registry
- 12 December 2025
- journal article
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 81 (1) , 44-55
Abstract
The predictive role of right ventricular dysfunction (RVD) in patients with functional mitral regurgitation (FMR) undergoing transcatheter edge-to-edge repair (TEER), as well as RV remodelling following the procedure, remains uncertain. We evaluated the prognostic impact of pre-procedural three-dimensional (3D) right ventricular ejection fraction (RVEF) in patients with FMR. Additionally, we assessed the RV reverse remodelling (RVRR) based on 3D volumes and ejection fraction six months after the procedure. Data from 74 patients treated with TEER for FMR were prospectively collected. Pre-procedural RVD, defined as 3D RVEF ≤45%, was observed in 47 patients (63.5%). Patients were divided into three groups according to pre-procedural 3D-RVEF: no RVD (No-RVD, RVEF >45%, n = 27), mild-to-moderate RVD (MRVD, RVEF 31-45%, n = 36), and severe RVD (SRVD, RVEF ≤30%, n = 11). Patients with SRVD demonstrated a significant higher rate of all-cause mortality compared with the other two groups (p = 0.04) and RVEF ≤ 30% was associated with all-cause death, independently of left ventricular ejection fraction (LVEF) and left atrial volume index (LAVi) (HR: 3.72, 95% CI 1.12-12.30, p = 0.03). At 6-month follow-up, only patients with pre-procedural MRVD showed a significant reduction in 3D RV volumes and an improvement in RVEF compared to baseline (p < 0.05). RVD was common among patients undergoing mitral TEER for FMR. Those with pre-procedural SRVD had worse mid-term survival compared to patients with MRVD and No-RVD. The group with MRVD was the only one to demonstrate an RVRR six months after the procedure.Keywords
This publication has 38 references indexed in Scilit:
- Evolution of tricuspid regurgitation after transcatheter edge‐to‐edge mitral valve repair for secondary mitral regurgitation and its impact on mortalityEuropean Journal of Heart Failure, 2022
- Prognostic significance of right ventricle to pulmonary artery coupling in patients with mitral regurgitation treated with the MitraClip systemCatheterization and Cardiovascular Interventions, 2021
- Right Ventricular Dysfunction and Tricuspid Regurgitation in Functional Mitral RegurgitationESC Heart Failure, 2021
- Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitationEuropean Journal of Heart Failure, 2021
- Real-World Safety and Efficacy of Transcatheter Mitral Valve Repair With MitraClip: Thirty-Day Results From the Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO)Cardiovascular Revascularization Medicine, 2020
- New Directions in Right Ventricular Assessment Using 3-Dimensional EchocardiographyJAMA Cardiology, 2019
- Prognostic Significance of Right Ventricular Dysfunction in Patients With Functional Mitral Regurgitation Undergoing MitraClipThe American Journal of Cardiology, 2016
- Percutaneous Mitral Valve Repair Preserves Right Ventricular FunctionJournal of the American Society of Echocardiography, 2014
- Right Ventricular Function in Acute Pulmonary Embolism: A Combined Assessment by Three-Dimensional and Speckle-Tracking EchocardiographyJournal of the American Society of Echocardiography, 2014
- EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 2012